Press Release: InBios : InBios Receives FDA EUA for COVID-19 Neutralizing Antibody ELISA
SEATTLE (PRWEB) October 28, 2021 InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that it received Emergency...
Read full article »
President
Estela Raychaudhuri
InBios is a Washington-based biotechnology firm that develops and commercializes immunodiagnostic devices for infectious diseases and biothreats.
Read more